BBR Partners’s FibroGen FGEN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-658
| Closed | -$5.1K | – | 246 |
|
|
2025
Q1 | $5.1K | Hold |
658
| – | – | ﹤0.01% | 244 |
|
|
2024
Q4 | $8.71K | Hold |
658
| – | – | ﹤0.01% | 248 |
|
|
2024
Q3 | $6.57K | Hold |
658
| – | – | ﹤0.01% | 241 |
|
|
2024
Q2 | $14.7K | Sell |
658
-8,000
| -92% | -$178K | ﹤0.01% | 219 |
|
|
2024
Q1 | $509K | Buy |
8,658
+8,000
| +1,216% | +$470K | 0.04% | 140 |
|
|
2023
Q4 | $14.6K | Buy |
+658
| New | +$14.6K | ﹤0.01% | 192 |
|
|
2021
Q2 | – | Sell |
-282
| Closed | -$245K | – | 205 |
|
|
2021
Q1 | $245K | Hold |
282
| – | – | 0.02% | 181 |
|
|
2020
Q4 | $262K | Hold |
282
| – | – | 0.02% | 156 |
|
|
2020
Q3 | $290K | Hold |
282
| – | – | 0.02% | 143 |
|
|
2020
Q2 | $286K | Hold |
282
| – | – | 0.04% | 132 |
|
|
2020
Q1 | $245K | Hold |
282
| – | – | 0.04% | 121 |
|
|
2019
Q4 | $303K | Hold |
282
| – | – | 0.03% | 146 |
|
|
2019
Q3 | $261K | Hold |
282
| – | – | 0.04% | 110 |
|
|
2019
Q2 | $319K | Hold |
282
| – | – | 0.05% | 94 |
|
|
2019
Q1 | $383K | Hold |
282
| – | – | 0.05% | 99 |
|
|
2018
Q4 | $327K | Buy |
282
+20
| +8% | +$23.2K | 0.04% | 111 |
|
|
2018
Q3 | $398K | Hold |
262
| – | – | 0.06% | 75 |
|
|
2018
Q2 | $410K | Hold |
262
| – | – | 0.07% | 66 |
|
|
2018
Q1 | $303K | Hold |
262
| – | – | 0.05% | 71 |
|
|
2017
Q4 | $311K | Buy |
262
+40
| +18% | +$47.5K | 0.06% | 56 |
|
|
2017
Q3 | $299K | Buy |
+222
| New | +$299K | 0.06% | 46 |
|